Access to advanced cancer care shouldn't depend on where you live. That’s why @UPMCHillmanCC has brought the latest theranostic treatments to UPMC Altoona. Partnering w/local rad/onc & nuclear med teams, we have treated our 1st 5 patients! Just the beginning! @PittHealthSci

Nice talk by my colleague @pnbarry on de-escalation of radiation treatment in low molecular risk breast cancer at ARS. @UPMCHillmanCC @HSkinnerMDPhD @ArsRocket

It has been great mentoring Vignesh and Abhay who are both outstanding undergraduate students at Pitt. I’m proud of both of their accomplishments and really happy that Abhay’s hard work was recognized at the AACR undergraduate student poster competition.

What a great brainstorm of ideas and common ground for collaborations in the field of Immunotherapy and Radiotherapy Combination. A big Thank you to the Forbeck Research Foundation for brining us together. 'The hope is to shorten the cancer research timetable.' @ForbeckResearch

Excited to share our new publication which shows that low dose radiopharmaceutical therapy can enhance efficacy of immune checkpoint blockade in “cold” tumors. @ZachMorrisMDPhD @artlab_wisc @JosephGrudzins1 @UPMCHillmanCC @UWCarbone @IOTNmoonshot stm.sciencemag.org/content/1…

Excited to moderate this SITC webinar (open to all) tmrw for trainees interested in applying for industry or academic positions.

🆕Recommended by the Editors! Decreased Local Immune Response and Retained #HPV Gene Expression during Chemoradiotherapy are Associated with Treatment Resistance and Death from #cervicalcancer | 👉 buff.ly/2O1DhDU @pipcosper @IvanGonzalezMD @WashURadOnc @SitemanCenter

Dr. Thomas Marron presenting an update of our SITC Sparkathon team project. @sitcancerECS #SITC19